HLA-DPB1∗04:01 protects genetically susceptible children from celiac disease autoimmunity in the TEDDY study

American Journal of Gastroenterology

Volumn 110, Issue 6, 2015, Pages 915-920

  Hadley, David ^a,b   Hagopian, William ^c   Liu, Edwin ^d,e   She, Jin Xiong ^f   Simell, Olli ^g   Akolkar, Beena ^h   Ziegler, Anette G ^i,j,k   Rewers, Marian ^d   Krischer, Jeffrey P ^l   Chen, Wei Min ^m   Onengut Gumuscu, Suna ^m   Bugawan, Teodorica L ⁿ   Rich, Stephen S ^m   Erlich, Henry ^o   Agardh, Daniel ^l,p  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b TransMed Systems   (United States)

^c PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^d CHILDREN S HOSPITAL COLORADO   (United States)

^e UNIVERSITY OF COLORADO DENVER   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

^g UNIVERSITY OF TURKU   (Finland)

^h NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

ⁱ INSTITUTE OF EPIDEMIOLOGY   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k Forschergruppe Diabetes EV   (Germany)

^l UNIVERSITY OF SOUTH FLORIDA   (United States)

^m UNIVERSITY OF VIRGINIA   (United States)

ⁿ ROCHE MOLECULAR SYSTEMS   (United States)

^o CHILDREN S HOSPITAL OAKLAND   (United States)

^p LUND UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DRB3 ANTIGEN; HLA DRB4 ANTIGEN; UNCLASSIFIED DRUG; AUTOANTIBODY; GUANINE NUCLEOTIDE BINDING PROTEIN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA-DPB1*04:01 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ALLELE; ALLOGENEIC RESTRICTION; ARTICLE; AUTOIMMUNITY; CELIAC DISEASE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SURVEILLANCE; ETHNIC DIFFERENCE; FEMALE; FINN (CITIZEN); FOLLOW UP; GENE DOSAGE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SELF REPORT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDISH CITIZEN; AUTOIMMUNE DISEASE; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFANT; NEWBORN; PROPORTIONAL HAZARDS MODEL; PROTECTION; STATISTICAL MODEL;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GTP-BINDING PROTEINS; HLA-DP BETA-CHAINS; HLA-DQ ANTIGENS; HLA-DR3 ANTIGEN; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; PROTECTIVE FACTORS; TRANSGLUTAMINASES;

EID: 84930757675     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.150     Document Type: Article

References (27)

1. Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3: 797-801.
2. Lundin KE, Scott H, Hansen T et al. Gliadin-specific, HLA-DQ (alpha 1∗0501, beta 1∗0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178: 187-96.
3. Ploski R, Ek J, Thorsby E et al. On the HLA-DQ (alpha 1∗0501, beta 1∗0201)-associated susceptibility in celiac disease: a possible gene dosage Effect of DQB1∗0201. Tissue Antigens 1993;41: 173-7.
4. Murray JA, Moore SB, Van Dyke CT et al. HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol 2007;5: 1406-12.
5. Margaritte-Jeannin P, Babron MC, Bourgey M et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens 2004;63: 562-7.
6. Liu E, Lee HS, Aronsson CA et al. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med 2014;371: 42-9.
7. Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 2012;18: 6036-59.
8. Kagnoff MF, Harwood JI, Bugawan TL et al. Structural analysis of the HLA-DR,-DQ, and-DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype. Proc Natl Acad Sci USA 1989;86: 6274-8.
9. Smyth DJ, Plagnol V, Walker NM et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359: 2767-77.
10. Ahn R, Ding YC, Murray J et al. Association analysis of the extended MHC region in celiac disease implicates multiple independent susceptibility loci. PLoS One 2012;7: e36926.
11. Bugawan TL, Angelini G, Larrick J et al. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Nature 1989;339: 470-3.
12. Caffrey C, Hitman GA, Niven MJ et al. HLA-DP and coeliac disease: family and population studies. Gut 1990;31: 663-7.
13. Hagopian WA, Erlich H, Lernmark A et al. The environmental determinants of diabetes in the young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 2011;12: 733-43.
14. Vehik K, Fiske SW, Logan CA et al. Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY. Diabetes Metab Res Rev 2013;29: 557-67.
15. Williams AJ, Annis P, Lock RJ et al. Evaluation of a high-throughput second antibody radiobinding assay for measuring IgA antibodies to human tissue transglutaminase. J Immunol Methods 1999;228: 81-5.
16. Jia X, Han B, Onengut-Gumuscu S et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 2013;8: e64683.
17. Tn C, Hadley D, Lee HS et al. Role of Type 1 diabetes associated SNPs on risk of autoantibody positivity in the TEDDY Study. Diabetes 2014;64: 1818-29.
18. Sollid LM, Pos W, Wucherpfennig KW. Molecular mechanisms for contribution of MHC molecules to autoimmune diseases. Curr Opin Immunol 2014;31C: 24-30.
19. Romanos J, Ros A, Kumar V et al. Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants. Gut 2014;63: 415-22.
20. Trynka G, Hunt KA, Bockett NA et al. Dense genotyping identifi es and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011;43: 1193-201.
21. Noble JA, Valdes AM, Thomson G et al. The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes 2000;49: 121-5.
22. Yoshimura S, Isobe N, Yonekawa T et al. Genetic and infectious profi les of Japanese multiple sclerosis patients. PLoS One 2012;7: e48592.
23. Perdriger A, Guggenbuhl P, Chales G et al. The role of HLA-DR-DR and HLA-DR-DP interactions in genetic susceptibility to rheumatoid arthritis. Hum Immunol 1996;46: 42-8.
24. Koc CK, Sallakci N, Akman-Karaka A et al. Human leukocyte antigens class I and class II in patients with pemphigus in southern Turkey. Int J Dermatol 2013;52: 53-8.
25. Watts RA, MacGregor AJ, Mackie SL. HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis. Rheumatology (Oxford) 2014;54: 359-62.
26. Barrett JC, Clayton DG, Concannon P et al. Genome-wide association study and meta-analysis fi nd that over 40 loci aff ect risk of type 1 diabetes. Nat Genet 2009;41: 703-7.
27. Price P, Witt C, Allcock R et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999;167: 257-74.